RIPK4/PEBP1 axis promotes pancreatic cancer cell migration and invasion by activating RAF1/MEK/ERK signaling

por Qi, Zi-Hao, Xu, Hua-Xiang, Zhang, Shi-Rong, Xu, Jin-Zhi, Li, Shuo, Gao, He-Li, Jin, Wei, Wang, Wen-Quan, Wu, Chun-Tao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Publicado 2018

The Significance of Liquid Biopsy in Pancreatic Cancer

por Qi, Zi-Hao, Xu, Hua-Xiang, Zhang, Shi-Rong, Xu, Jin-Zhi, Li, Shuo, Gao, He-Li, Jin, Wei, Wang, Wen-Quan, Wu, Chun-Tao, Ni, Quan-Xing, Yu, Xian-Jun, Liu, Liang
Publicado 2018

Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016

Retraction: Mutant p53 determines pancreatic cancer poor prognosis to pancreatectomy through upregulation of cavin-1 in patients with preoperative serum CA19-9 ≥ 1,000 U/mL

por Xiang, Jin-Feng, Wang, Wen-Quan, Liu, Liang, Xu, Hua-Xiang, Wu, Chun-Tao, Yang, Jing-Xuan, Qi, Zi-Hao, Wang, Ya-Qi, Xu, Jin, Liu, Chen, Long, Jiang, Ni, Quan-Xing, Li, Min, Yu, Xian-Jun
Publicado 2016